Mechanics Bank Trust Department Has $317,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Mechanics Bank Trust Department cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 20.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,400 shares of the financial services provider’s stock after selling 600 shares during the quarter. Mechanics Bank Trust Department’s holdings in iShares Biotechnology ETF were worth $317,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Security National Bank of SO Dak boosted its stake in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. grew its stake in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its holdings in shares of iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares in the last quarter. Capital Investment Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its holdings in shares of iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of IBB opened at $132.65 on Tuesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business has a 50-day simple moving average of $136.32 and a two-hundred day simple moving average of $141.84.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.